Clinical Trials Directory

Trials / Completed

CompletedNCT06505239

Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication

A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Assess the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication (METAL-2)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Quantum Biopharma · Industry
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

This will be a (2 visit) double-blind, randomized, placebo crossover design clinical study to assess the potential benefits of FSD-F2R6-A-CP versus a placebo by assessing its impact on side effect profiles as well as cognitive abilities, motor abilities, and breath alcohol concentration following ingestion of alcohol followed by the dietary supplement or placebo. This study will enroll healthy men and women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFSD-F2R6-A-CPFSD-F2R6-A-CP is a unique dietary supplement with natural ingredients, vitamins and minerals that potentially enhances cognition, replenishes cofactors needed for alcohol metabolism and may accelerate alcohol metabolism in the body.
DIETARY_SUPPLEMENTPlaceboPlacebo drink designed to match FSD-F2R6-A-CP in color and taste.

Timeline

Start date
2024-07-12
Primary completion
2024-11-07
Completion
2024-11-07
First posted
2024-07-17
Last updated
2025-05-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06505239. Inclusion in this directory is not an endorsement.